MM tumors with high KPC1 protein showed robust KPC1 signals that were accompanied by low levels of ZEB1 and CDH2; conversely, MM tumors with low KPC1 exhibited low KPC1 protein levels, but markedly increased ZEB1 and CDH2 protein levels (Fig. 6A). Here, CDH2 is linked to Miyoshi myopathy.